EarningsQ1 2024 Earnings Report

BioMarin Pharmaceutical (BMRN) Q1 2024 Earnings Report

0 Followers

MX:BMRN Q1 2024 EPS Results

Actual EPS$8.69

Consensus EPS$5.89

Beat/MissBeat by +$2.79

One Year Ago EPS$5.10

Actual Revenue$12.27B

Expected Revenue$12.31B

Beat/MissMissed by -$35.37M

YoY Revenue Growth+9.61%

QuarterQ1 2024

Date04/24/2024

TimeAfter Close

Conference CallWednesday, April 24, 2024

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

MX:BMRN Q1 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	-1.57 / -	-3.021	―
Aug 06, 2026	2026 (Q2)	17.88 / 22.66	23.225	-2.44% (-0.57)
May 04, 2026	2026 (Q1)	13.07 / 14.35	17.938	-20.00% (-3.59)
Feb 23, 2026	2025 (Q4)	3.19 / -4.53	12.085	-137.50% (-16.62)
Oct 27, 2025	2025 (Q3)	-5.29 / -3.02	10.385	-129.09% (-13.41)
Aug 04, 2025	2025 (Q2)	16.26 / 23.23	10.385	123.64% (+12.84)
May 01, 2025	2025 (Q1)	13.48 / 17.94	8.686	106.52% (+9.25)
Feb 19, 2025	2024 (Q4)	10.08 / 12.08	2.077	481.82% (+10.01)
Oct 29, 2024	2024 (Q3)	10.03 / 10.39	3.965	161.90% (+6.42)
Aug 05, 2024	2024 (Q2)	6.76 / 10.39	5.476	89.66% (+4.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed